Drug Discovery Unchained: What The Drug!? #2

webinar

Wed, 14 Aug 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

Drug Discovery Unchained: What The Drug!? #2

What happens when somebody asks you to do drug discovery? No preparation, no script, no nothing. Just live performing and sharing your thoughts.

This is “What The Drug!?”: a live session tackling a drug discovery challenge using BioSolveIT tools, with the aim of reaching a conclusion in a reasonable time frame. What is the challenge? We do not know. Everything will be revealed during the stream, and we will see how things unfold.

The first session was a good starting point, but let’s see how things develop. Dive into the session, discuss together, and explore on-the-fly compound design.

Current news

Freedom Space 4.0: 142 Billion Molecules for Faster Hit Discovery!
February 12, 2025 09:00 CET
Freedom Space (launched by Chemspace) has undergone a significant expansion, now reaching an impressive 142 billion compounds in its latest version 4.0. This update is a substantial leap forward in synthetic accessibility and diverse chemical representation, offering researchers an expanisve resource for drug discovery and hit identification. Expanding the Reach...
Read on
category
Software
'Electra' Update: HPSee Version 2.1
January 21, 2025 09:01 CET
The virtual workflow environment platform HPSee enters the next stage with the 2.1 update. This version introduces powerful new features and enhancements to improve usability, security, and compatibility: Dynamic Library Handling: Rename libraries and update descriptions directly via the API or Admin Dashboard to better track updates, differentiate libraries, and...
Read on
category
Software
SeeSAR 14.1 'Atlas' — Energy Minimization, Chemical Space Docking™, Pharmacophores
January 21, 2025 09:00 CET
More polished, more finesse, more efficiency – that’s version 14.1 of SeeSAR ‘Atlas’. Once again, we’ve rolled up our sleeves to refine and tune the engines and gears of our drug design dashboard SeeSAR. While we were at it, we also put extra effort into new features that will take...
Read on